ABSTRACT
Retinol is a fat-soluble vitamin that plays an essential role in many biological processes throughout the human lifespan. Previous work has characterised genetic influences on circulating retinol; however, small sample sizes have limited our ability to fully appreciate the genetic architecture of this trait. In this study, we performed the largest genome-wide association study (GWAS) of retinol to date in up to 22,274 participants. We identified eight common variant loci associated with retinol, as well as a rare-variant signal. An integrative gene prioritisation pipeline supported novel retinol-associated genes outside of the main retinol transport complex (RBP4:TTR) related to lipid biology, energy homeostasis, and endocrine signalling. Genetic proxies of circulating retinol were then used to estimate causal relationships with almost 20,000 clinical phenotypes via a phenome-wide Mendelian randomisation study (MR-pheWAS). The MR-pheWAS suggested that retinol may exert causal effects on inflammation, adiposity, ocular measures, the microbiome, and MRI-derived brain phenotypes, amongst several others. Conversely, circulating retinol may be causally influenced by factors including lipids and renal function. Finally, we demonstrated how a retinol polygenic score could identify individuals who are more likely to fall outside of the normative range of circulating retinol for a given age. In summary, this study provides a comprehensive evaluation of the genetics of circulating retinol, as well as revealing traits which should be prioritised for further clinical investigation with respect to retinol related therapies or nutritional intervention.
Competing Interest Statement
P.S. is now a full-time employee of GlaxoSmithKline. The remaining authors declare no competing financial interests.
Funding Statement
TwinsUK is funded by the Wellcome Trust Medical Research Council Versus Arthritis European Union Horizon 2020 Chronic Disease Research Foundation (CDRF) Zoe Ltd the National Institute for Health and Care Research (NIHR) Clinical Research Network (CRN) and Biomedical Research Centre based at Guys and St Thomas NHS Foundation Trust in partnership with Kings College London. P.S. was supported by a Rutherford Fund Fellowship from the Medical Research Council (grant no. MR/S003746/1). Participants in the INTERVAL trial were recruited with the active collaboration of NHS Blood and Transplant England (www.nhsbt.nhs.uk) which has supported field work and other elements of the trial. DNA extraction and genotyping were co-funded by the National Institute for Health and Care Research (NIHR) the NIHR BioResource (http://bioresource.nihr.ac.uk) and the NIHR Cambridge Biomedical Research Centre (BRC-1215-20014). The academic coordinating centre for INTERVAL was supported by core funding from the: NIHR Blood and Transplant Research Unit (BTRU) in Donor Health and Genomics (NIHR BTRU-2014-10024) NIHR BTRU in Donor Health and Behaviour (NIHR203337) UK Medical Research Council (MR/L003120/1) British Heart Foundation (SP/09/002; RG/13/13/30194; RG/18/13/33946) and NIHR Cambridge BRC (BRC-1215-20014; NIHR203312). Metabolon metabolomics assays in INTERVAL were funded by the: NIHR BioResource NIHR Cambridge Biomedical Research Centre (BRC-1215-20014) Wellcome Trust grant number 206194 and BioMarin Pharmaceutical Inc. The academic coordinating centre thank blood donor centre staff and blood donors for participating in the INTERVAL trial. This work was supported by Health Data Research UK which is funded by the UK Medical Research Council Engineering and Physical Sciences Research Council Economic and Social Research Council Department of Health and Social Care (England) Chief Scientist Office of the Scottish Government Health and Social Care Directorates Health and Social Care Research and Development Division (Welsh Government Public Health Agency (Northern Ireland) British Heart Foundation and Wellcome. For the purpose of open access the author(s) has applied a Creative Commons Attribution (CC BY) licence to any Author Accepted Manuscript version arising from this submission. Access to the TwinsUK cohort for this study was funded by a Hunter Medical Research Institute (Newcastle Australia) Precision Medicine Research Program Pilot Grant (W.R.R). C.E.C. is supported by an investigator grant from the National Health and Medical Research Council (NHMRC). M.A.D is supported by an investigator grant from the National Health and Medical Research Council (NHMRC). P.S. was supported by a Rutherford Fund Fellowship from the Medical Research Council (grant no. MR/S003746/1).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The data access committee of TwinsUK gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
DATA AVAILABILITY
Genome-wide summary statistics will be uploaded to GWAS catalog upon final publication. In the interim, summary statistics can also be found at the following: 10.5281/zenodo.7905523. TwinsUK data can be accessed by approve researchers upon application (https://twinsuk.ac.uk/resources-for-researchers/our-data/).
